| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/30/2009 | WO2009155726A2 Humanization of rabbit antibodies using a universal antibody framework |
| 12/30/2009 | WO2009155725A1 Solubility optimization of immunobinders |
| 12/30/2009 | WO2009155724A2 Stable and soluble antibodies inhibiting vegf |
| 12/30/2009 | WO2009155723A2 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
| 12/30/2009 | WO2009155670A2 Pharmaceutical compositions of antibodies for diseases caused by viruses |
| 12/30/2009 | WO2009140418A3 Compositions and methods for treating arthritis and/or diseases involving cartilage degeneration |
| 12/30/2009 | WO2009132251A3 Methods and compositions comprising anti-idiotypic antibodies to anti-mmp-14 antibodies |
| 12/30/2009 | WO2009126965A3 Compositions, methods and uses for modulations of brca1 |
| 12/30/2009 | WO2009124281A3 Novel antibodies against cancer target block tumor growth, angiogenesis and metastasis |
| 12/30/2009 | WO2009111508A3 Metalloproteinase 9 and metalloproteinase 2 binding proteins |
| 12/30/2009 | WO2009100105A3 Inhibitors of oncogenic isoforms and uses thereof |
| 12/30/2009 | WO2009086352A3 Cynomolgus toll-like receptor 3 |
| 12/30/2009 | WO2009058383A3 Ligand |
| 12/30/2009 | WO2009025867A3 Compositions of humanized notch fusion proteins and methods of treatment |
| 12/30/2009 | WO2008131215A3 Engineered phosphite dehydrogenase mutants |
| 12/30/2009 | EP2138582A2 DNA and specific peptides or proteins of bacteria of the species neisseria meningitidis, methods for obtaining same and their biological applications |
| 12/30/2009 | EP2138576A1 Anti-claudin-4 antibody |
| 12/30/2009 | EP2138513A1 Pharmaceutical compositions of antibodies for diseases caused by viruses |
| 12/30/2009 | EP2138512A1 Humanized anti-NGF antibodies |
| 12/30/2009 | EP2138511A1 HER3 as a determinant for the prognosis of melanoma |
| 12/30/2009 | EP2137218A2 Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9) |
| 12/30/2009 | EP2137217A1 Methods for inhibiting the binding of endosialin to ligands |
| 12/30/2009 | EP2137216A2 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer |
| 12/30/2009 | EP2137215A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 12/30/2009 | EP2137214A1 Novel human anti-r7v antibodies and uses thereof |
| 12/30/2009 | EP2136839A2 Stable antibody formulations |
| 12/30/2009 | EP2136834A1 A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof |
| 12/30/2009 | EP1689432B1 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 12/30/2009 | EP1272663B1 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 12/30/2009 | EP1117774B1 Method for generating diversity |
| 12/30/2009 | EP1066394B1 Novel basal endosperm transfer cell layer (betl) specific genes |
| 12/30/2009 | CN101616935A Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 12/30/2009 | CN101616934A Dr6 antagonists and uses thereof in treating neurological disorders |
| 12/30/2009 | CN101616933A Novel anti-CD38 antibodies for the treatment of cancer |
| 12/30/2009 | CN101616932A Crystalline anti-hTNFalpha antibodies |
| 12/30/2009 | CN101616653A Human antibodies that bind human IL-12 and methods for producing |
| 12/30/2009 | CN101613705A Optimizing glycan processing in plants |
| 12/30/2009 | CN101613688A Von willebrand factor (vWF)-cleaving protease |
| 12/30/2009 | CN101613409A PDGFR-alpha antibody |
| 12/30/2009 | CN101613397A Neisserial antigenic peptides |
| 12/30/2009 | CN101612402A Interferon antagonist and use of Flt3L interferon |
| 12/30/2009 | CN100575489C A process for recovering polypeptides that unfold reversibly from a polypeptide repertoire |
| 12/30/2009 | CN100575482C Novel cytokine zcytor17 ligand |
| 12/30/2009 | CN100575364C Antibodies for inhibiting blood coagulation and methods of use thereof |
| 12/30/2009 | CN100575363C Human source anti-A botulinum neurotoxin genetic engineering antibody and preparation method and use thereof |
| 12/30/2009 | CN100575362C Process for preparing yelk antibody with high bioactivity |
| 12/30/2009 | CN100575361C Humanized single chain antibody for anti-human cytomegalovirus envelope glycoprotein |
| 12/30/2009 | CN100574840C Purification of immunoglobulins |
| 12/30/2009 | CN100574803C Use of immunoregulation antibody for the treatment of neoplastic disorders |
| 12/30/2009 | CA2729226A1 Pharmaceutical compositions of antibodies for diseases caused by viruses |
| 12/30/2009 | CA2729095A1 Antibody producing non-human mammals |
| 12/30/2009 | CA2729012A1 Ang-2 inhibition to treat multiple sclerosis |
| 12/30/2009 | CA2728829A1 Solubility optimization of immunobinders |
| 12/30/2009 | CA2728004A1 Humanization of rabbit antibodies using a universal antibody framework |
| 12/30/2009 | CA2727992A1 Stable and soluble antibodies inhibiting tnfa |
| 12/30/2009 | CA2727839A1 Stable and soluble antibodies inhibiting vegf |
| 12/30/2009 | CA2714940A1 Her3 as a determinant for the prognosis of melanoma |
| 12/29/2009 | US7640114 Method of diagnosis of cancer based on gene expression profiles in cells |
| 12/29/2009 | US7638619 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
| 12/29/2009 | US7638608 Assay for the separation and quantification of hemagglutinin antigens |
| 12/29/2009 | US7638607 Urocortin proteins and uses thereof |
| 12/29/2009 | US7638606 IL-4R antagonists; allergies and asthma |
| 12/29/2009 | US7638605 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 12/29/2009 | US7638604 Monoclonal antibodies against interleukin-22 |
| 12/29/2009 | US7638603 Use in diagnosis and treatment of cytokine disorders such as tumor metastasis, angiogenesis, cellular migration and ovulation, as well as neurogenesis |
| 12/29/2009 | US7638602 Heterodimeric human cytokine receptor comprising Zcytor16/Zcytor11 components for use in treatment of cell proliferative, inflammatory and immune disorders |
| 12/29/2009 | US7638601 Transient receptor potential channel TRPM8 and its use |
| 12/29/2009 | US7638598 ErbB interface peptidomimetics and methods of use thereof |
| 12/29/2009 | US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 12/29/2009 | US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/29/2009 | US7638326 Activation and expansion of T-cells using an engineered multivalent signaling platform |
| 12/29/2009 | US7638325 Microarray for activation and or stimulation of lymphocytes; immunotherapy; anticarcinogenic agents; viricides; bactericides; fungicides |
| 12/29/2009 | US7638323 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
| 12/29/2009 | US7638311 using branching enzyme from a bacterium of the genus Neisseria; for use in pharmaceutical/cosmetic industries |
| 12/29/2009 | US7638291 biological conjugate drug; used in immunodiagnostic assays to compete with topiramate for anti-topiramate antibodies; competitive bonding; finding the right dosage of anti-epileptic drug for each patient |
| 12/29/2009 | US7638286 producing an antibody by inoculating an animal with a polypeptide; monoclonal antibody specifically binds to a zalpha11 polypeptide; treating blood disorders |
| 12/29/2009 | US7638284 analysis; detect IgA deficiency in a mammal, using antibody specific for Immunoglobulin A Inducing Protein; polyclonal antibody; monoclonal antibody; immunoassay for mammalian mucosal immune system |
| 12/29/2009 | US7638269 Viral capsid assembly intermediates and methods of production |
| 12/29/2009 | US7638136 fusion proteins; encode hyperimmune serum reactive antigen or fragment thereof; immunogens |
| 12/29/2009 | US7638135 Collagen-binding proteins from enterococcal bacteria |
| 12/29/2009 | US7638133 transformed with an expression vector that has a polynucleotide encoding a foreign antigenic protein, wherein the polynucleotide is a modified one in which the third position of each codon is substituted with G or C without a change of an amino acid; against human immunodeficiency virus infection |
| 12/29/2009 | US7638131 Coccidiosis poultry vaccine |
| 12/29/2009 | US7638126 Methods of treating pain and inflammation in neuronal tissue using antagonists of IL-31, IL31Ra and/or OSMRb |
| 12/29/2009 | US7638125 different epitopes are located within the binding domain of the natural ligand(s) of said receptor; first and second antigen-binding site binds to a different epitope on the same EGFR molecule; anticarcinogenicb antimetastasis agents |
| 12/29/2009 | US7638124 Antigen-presenting complex-binding compositions and uses thereof |
| 12/29/2009 | US7638122 Stat3 antagonists and their use as vaccines against cancer |
| 12/29/2009 | US7638121 Preparing human recipient for graft; administer to individual irradiated thymocytes, CD-2 monoclonal antibody, donor peripheral blood progenitor and immunosuppressants; monitor for transplant rejection |
| 12/29/2009 | CA2153507C A fas ligand, a fragment thereof and dna encoding the same |
| 12/29/2009 | CA2147839C The st-b17 serotonin receptor |
| 12/24/2009 | US20090320149 Expression vectors |
| 12/24/2009 | US20090318677 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 12/24/2009 | US20090318672 Antibodies to pro352 |
| 12/24/2009 | US20090318354 Use of at least one isoform of progesterone receptor membrane component 1 (PGRMC1) |
| 12/24/2009 | US20090318348 Proteins, Nucleic Acids Encoding the Same, and Associated Methods of Use |
| 12/24/2009 | US20090318340 IL-17 homologous polypeptides and therapeutic uses thereof |
| 12/24/2009 | US20090317921 Antibody to inhibin/ activin beta-b subunit |
| 12/24/2009 | US20090317920 Hapten compound and antibody |
| 12/24/2009 | US20090317903 Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors |
| 12/24/2009 | US20090317830 Hepatitis c virus ns2/3 assay |
| 12/24/2009 | US20090317827 Receptor In Dendritic Cells |